there isn't Erygel Generic Name: erythromycin Dosage Form: topical gel Overview Side Effects Dosage Professional Pregnancy More Breastfeeding Warnings User Reviews Support Group Q & A Pricing & Coupons Erygel- erythromycin gel Prestium Pharma, Inc. Prestium Pharma, Inc. Erygel (Erythromycin) Topical Gel USP, 2% For Dermatologic Use Only Not for Ophthalmic Use Rx Only Erygel Description Erygel Topical Gel USP, 2% contains erythromycin (3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3- C -methyl-3- O -methyl-α-L- ribo -hexopyranosyl)oxy]-14-ethyl-7, 12, 13-trihydroxy-3, 5, 7, 9, 11, 13-hexamethyl-6-[[3, 4, 6,-trideoxy-3-(dimethylamino)-β-D- xylo- hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione), for topical dermatological use. Erythromycin is a macrolide antibiotic produced from a strain of Saccaropolyspora erythraea (formerly Streptomyces erythreus ). It is a base and readily forms salts with acids. Chemically, erythromycin is C37H67NO13. It has the following structural formula: Erythromycin has a molecular weight of 733.94. It is a white or slightly yellow, odorless or practically odorless, bitter crystalline powder. Erythromycin is very soluble in very polar organic solvents such as alcohols, acetone, chloroform, acetonitrile and ethyl acetate. It is moderately soluble in less polar solvents such as ether, dichloroethylene and amyl acetate. It is slightly soluble in nonpolar solvents such as hexane. It is very poorly soluble in water. Each gram of Erygel Topical Gel USP, 2% contains 20 mg of erythromycin USP in a vehicle consisting of dehydrated alcohol and hydroxypropyl cellulose. Slideshow Newborn Baby Health: 8 Woes From Cradle Cap And Colic To Whooping Cough Erygel - Clinical Pharmacology The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. MICROBIOLOGY Erythromycin acts by inhibition of protein synthesis in susceptible organisms by reversibly binding to 50S ribosomal subunits, thereby inhibiting translocation of aminoacyl transfer-RNA and inhibiting polypeptide synthesis. Antagonism has been demonstrated in vitro between erythromycin, lincomycin, chloramphenicol, and clindamycin. Indications and Usage for Erygel Erygel Topical Gel USP, 2% is indicated for the topical treatment of acne vulgaris. Contraindications Erygel Topical Gel USP, 2% is contraindicated in those individuals who have shown hypersensitivity to any of its components. Warnings Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents. Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is one primary cause of antibiotic-associated colitis . After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated. Mild cases of pseudomembranous colitis usually respond to drug discontinuation alone. In moderate to severe cases, consideration should be given to management with fluids and electrolytes, protein supplementation and treatment with an antibacterial drug clinically effective against C. difficile colitis. Precautions General - For topical use only; not for ophthalmic use. Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy effect may occur, especially with the use of peeling, desquamating or abrasive agents. Avoid contact with eyes and all mucous membranes. The use of antibiotic agents may be associated with the overgrowth of antibiotic-resistant organisms. If this occurs, discontinue use and take appropriate measures. Information for Patients Patients using Erygel Topical Gel USP, 2% should receive the following information and instructions: 1. This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes, nose, mouth, and all mucous membranes. 2. This medication should not be used for any disorder other than that for which it was prescribed. 3. Patients should not use any other topical acne medication unless otherwise directed by their physician. 4. Patients should report to their physician any signs of local adverse reactions. Carcinogenesis, Mutagenesis, Impairment of Fertility - No animal studies have been performed to evaluate carcinogenic and mutagenic potential, or effects on fertility of topical erythromycin. However, long-term (2-year) oral studies in rats with erythromycin ethylsuccinate and erythromycin base did not provide evidence of tumorigenicity. There was no apparent effect on male or female fertility in rats fed erythromycin (base) at levels up to 0.25% of diet. Pregnancy: Teratogenic Effects: Pregnancy Category B - There was no evidence of teratogenicity or any other adverse effect on reproduction in female rats fed erythromycin base (up to 0.25% of diet) prior to and during mating, during gestation and through weaning of two successive litters. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used in pregnancy only if clearly needed. Erythromycin has been reported to cross the placental barrier in humans, but fetal plasma levels are generally low. Nursing Women - It is not known whether erythromycin is excreted in human milk after topical application. However, erythromycin is excreted in human milk following oral and parenteral erythromycin administration. Therefore, caution should be exercised when erythromycin is administered to a nursing woman. Pediatric Use - Safety and effectiveness in pediatric patients have not been established. KEEP OUT OF REACH OF CHILDREN. Adverse Reactions In controlled clinical trials, the incidence of burning associated with erythromycin topical gel USP, 2% was approximately 25%. The following additional local adverse reactions have been reported occasionally: peeling, dryness, itching, erythema, and oiliness. Irritation of the eyes and tenderness of the skin have also been reported with the topical use of erythromycin. A generalized urticarial reaction, possibly related to the use of erythromycin, which required systemic steroid therapy has been reported. Erygel Dosage and Administration Erygel Topical Gel USP, 2% should be applied sparingly as a thin film to affected area(s) once or twice a day after the skin is thoroughly cleansed and patted dry. If there has been no improvement after 6 to 8 weeks, or if the condition becomes worse, treatment should be discontinued, and the physician should be reconsulted. Spread the medication lightly rather than rubbing it in. There are no data directly comparing the safety and efficacy of b.i.d. versus q.d. dosing. How is Erygel Supplied Erygel (Erythromycin) Topical Gel USP, 2% is available as follows: 30 g sealed metal tube (NDC 40076- 415 -30) 60 g sealed metal tube (NDC 40076- 415 -60) STORAGE Note - FLAMMABLE. Keep away from heat and flame. Store and dispense in original container. Keep tube tightly closed. Store at 20-25 C (68-77 F) [see USP Controlled Room Temperature]. Manufactured for: Prestium Pharma, Inc. Newtown, PA 18940 Manufactured by: DPT Laboratories, Ltd., San Antonio, TX 78215 Rev 08/15 140647 PRINCIPAL DISPLAY PANEL NDC 40076-415-30 Erygel (Erythromycin) Topical Gel USP 2% Net Wt 30 g PRINCIPAL DISPLAY PANEL NDC 40076-415-60 Erygel (Erythromycin) Topical Gel USP 2% Net Wt 60 g Erygel erythromycin gel Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:40076-415 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ERYTHROMYCIN (ERYTHROMYCIN) ERYTHROMYCIN 20 mg in 1 g Inactive Ingredients Ingredient Name Strength ALCOHOL HYDROXYPROPYL CELLULOSE, UNSPECIFIED Product Characteristics Color WHITE (slightly yellow, practically odorless) Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:40076-415-30 1 TUBE in 1 CARTON 1 30 g in 1 TUBE 2 NDC:40076-415-60 1 TUBE in 1 CARTON 2 60 g in 1 TUBE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA050617 01/27/2016 Labeler - Prestium Pharma, Inc. (078304674) Revised: 01/2016 Prestium Pharma, Inc. Next Pregnancy Warnings Print this page Add to My Med List More about Erygel (erythromycin topical) Side Effects During Pregnancy or Breastfeeding Dosage Information Support Group Pricing & Coupons En Español 0 Reviews Add your own review/rating Generic Availability Drug class: topical acne agents Consumer resources Erygel Erygel Topical (Advanced Reading) Professional resources Erythromycin topical (AHFS Monograph) Erythromycin Topical Solution (FDA) Other brands: Staticin , Akne-Mycin , Ery Pads , Erythra-Derm , T-Stat Related treatment guides Acne Perioral Dermatitis} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only Pregnancy Category Risk depends on usage N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Drug Class Topical acne agents Topical antibiotics Related Drugs topical acne agents clindamycin topical , erythromycin topical , tretinoin topical , tetracycline topical , dapsone topical , Finacea topical antibiotics mupirocin topical , erythromycin topical , Bactroban , neomycin topical , gentamicin topical , bacitracin topical Acne doxycycline , clindamycin topical , erythromycin topical , minocycline , tretinoin topical , tetracycline , dapsone topical , Accutane , Vibramycin , Retin-A , isotretinoin , Minocin , Ortho Tri-Cyclen , Yasmin , Monodox , adapalene topical , Yaz , TriNessa , Epiduo , Claravis , Benzaclin , Tazorac , Differin , Adoxa , More... Erygel Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first!} } a delegated
Sir Francis Bacon Erygel to procure
EmoticonEmoticon